A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

RCCS San Raffaele Scientific Institute in Milan researchers have discovered that hematopoietic stem cells (HSCs) adapt their lineage commitment during gene therapy based on the underlying genetic ...

European regulators have recommended Alofisel, a new advanced therapy to treat complex perianal fistulas in patients with Crohn’s disease. The treatment is now just a step away from being the ...

Doctors at Jewish Hospital Mercy Health are pioneering a new approach to treating multiple sclerosis (MS), offering hope to ...

Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

The study was recently published in the journal Cell Host ... and also cause disease-related shifts in the gut microbiome. Potential for new Crohn’s disease treatments Researchers believe ...

Enzo Porrello said he is working to develop stem cell treatments that can target the root cause of heart disease to ...

Read the paper: Long-term lineage commitment in hematopoietic stem cell gene therapy In many HSC gene-therapy procedures, functional copies of the disease-causing gene are delivered to cells using ...

driving the development of Crohn's disease, new research in mice suggests. If these findings hold true in humans, they could ultimately lead to the development of targeted treatments that get at ...

It is accomplished by stem cells that originate ... to improve the diagnosis and treatment of gastrointestinal diseases in humans, including diabetes, Crohn's disease, celiac disease, and cancer.

The study in Cell highlights microbial load's role in gut microbiome variation, suggesting it as a confounder in disease ...